In an effort by the Head of National Agency for Drugs and Foods Control (Badan Pengawas Obat dan Makanan – “BPOM”) to implement the adequate supervision of industrial pharmaceutical activities, as originally addressed under Regulation of the Minister of Health (“Minister”) No. 1799/MENKES/PER/XII/2010 on Industrial Pharmaceuticals, as amended through the issuance of Regulation of the Minister No. 16 of 2013 (“Regulation 1799/2010”),[1] the BPOM has issued Regulation No. 35 of 2019 on the Reporting of Industrial Pharmaceutical Activities (“Regulation 35/2019”).
......